Small organic molecule photosensitizer for photodynamic sterilization as well as preparation method and application of small organic molecule photosensitizer
By designing organic small molecule photosensitizers with intramolecular electron acceptor-donor structures, the problems of penetration and stability of existing photosensitizers in bacterial killing have been solved, achieving highly efficient bacterial killing and avoiding drug resistance.
Patent Information
- Application Number
- CN202511328030.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-09-17
- Publication Date
- 2026-01-02
AI Technical Summary
Existing photosensitizers face challenges in penetrating bacterial membranes, improving photostability and targeting, making it difficult to efficiently generate reactive oxygen species to kill bacteria, and they are prone to inducing drug resistance.
An organic small molecule photosensitizer was designed, which utilizes pyridine cations and furan-triphenylamine structures to construct an intramolecular electron acceptor-donor structure. It binds to bacteria through electrostatic interactions, generates reactive oxygen species to kill bacteria when exposed to light, and binds to Escherichia coli and Pseudomonas aeruginosa due to its lipophilic nature.
It achieves efficient generation of reactive oxygen species in aqueous solution, rapidly killing Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, avoiding drug resistance problems, and exhibits high dark toxicity and phototoxicity.
Smart Images

Figure CN121248583A_ABST
Abstract
Description
TECHNICAL FIELD
[0001] The application belongs to the technical field of organic photosensitizers, and particularly relates to an organic small-molecule photosensitizer for photodynamic sterilization and a preparation method and application thereof. BACKGROUND
[0002] The relationship between bacteria and humans has undergone a long and complex transformation, which plays an important role in maintaining stability in the ecosystem and protecting intestinal health, and can also cause a variety of diseases. At present, the problem of antibiotic abuse and bacterial drug resistance is becoming increasingly serious, and the effect of traditional antibiotic treatment of bacterial infection is gradually declining, so the problem of bacterial infection has become a major global health problem. The use of photosensitizers to produce active oxygen under light can effectively kill or inhibit the growth of bacteria, which can effectively solve the above problems. Among them, organic small-molecule photosensitizers have gradually become the focus of research due to their adjustable molecular structure, excellent biocompatibility and controllable optical physical properties.
[0003] Organic small-molecule photosensitizers can aggregate to form nanoparticles in aqueous solution, and can be converted from a ground state to an excited state by absorbing light energy under light. On the one hand, it promotes the movement of nanomolecules (including vibration, rotation, etc.) to consume energy, and on the other hand, it causes oxygen to be oxidized into various active oxygen with strong oxidizing properties through electron transfer. Strong oxidizing substances can continuously cause abnormal life activities of bacteria by oxidizing biological macromolecules such as proteins and lipids, destroy bacterial reproduction, and cause bacterial lysis and death, which can effectively overcome the biological membrane barrier and avoid the generation of drug resistance. However, existing photosensitizers still face challenges in penetrating the outer membrane of bacteria, improving light stability and targeting. Therefore, the development of new types of organic small-molecule photosensitizers with high active oxygen production efficiency under light has important research value for the development of photodynamic sterilization and antibacterial technology. SUMMARY
[0004] In view of the problems in the above background art, the purpose of the present application is to provide an organic small-molecule photosensitizer for photodynamic sterilization and a preparation method and application thereof.
[0005] In order to achieve the above-mentioned purpose, the technical scheme adopted by the present application is as follows: An organic small-molecule photosensitizer for photodynamic sterilization, the structure general formula of which is shown as formula (I): Formula (I).
[0006] The present application further provides a preparation method of an organic small-molecule photosensitizer for photodynamic sterilization, comprising the following steps: Step 1, 5-bromofuran-2-carboxaldehyde, 4-(diphenylamino)benzeneboronic acid, tetrakis(triphenylphosphine)palladium, potassium carbonate are added into xylene solvent, then deionized water is added, and the mixture is heated to 80-100℃ under argon protection and stirred for 8-16 hours. After the reaction is cooled to room temperature, a first reaction solution is obtained; After the first reaction solution is diluted with saturated brine, the water phase is extracted with ethyl acetate, and then all the organic phases are combined, dried, and concentrated by distillation under reduced pressure to obtain a first crude product. The first crude product is separated and purified by column chromatography on silica gel to obtain a yellow solid compound DC1-S1. The structure of the compound DC1-S1 is as follows: ; Step 2, compound DC1-S1, 2-(1-(4-pyridyl)ethylidene)malonitrile, acetic acid and 4-methylpiperidine are added into acetonitrile solvent. The obtained solution is heated to 65-85℃ under argon protection and stirred for 7-13 hours. After the reaction is cooled to room temperature, a second reaction solution is obtained. After the second reaction solution is diluted with saturated brine, the water phase is extracted with ethyl acetate, and then all the organic phases are combined, dried, and concentrated by distillation under reduced pressure to obtain a second crude product. The second crude product is separated and purified by column chromatography on silica gel to obtain a blue solid compound DC1-S2. The structure of the compound DC1-S2 is as follows: ; Step 3, compound DC1-S2 is dissolved in acetonitrile, and then methyl iodide is added. The obtained solution is heated to 60-80℃ and stirred for 4-8 hours. After the reaction is cooled to room temperature, a third reaction solution is obtained. After the third reaction solution is diluted with deionized water, the water phase is extracted with dichloromethane, and then all the organic phases are combined, dried, and concentrated by distillation under reduced pressure to obtain a third crude product. The third crude product is separated and purified by column chromatography on silica gel to obtain a purple solid photosensitizer represented by formula (I).
[0007] Further, in step 1, when preparing the compound DC1-S1, the molar ratio of 5-bromofuran-2-carboxaldehyde, 4-(diphenylamino)benzeneboronic acid, tetrakis(triphenylphosphine)palladium and potassium carbonate is 1:1.2: (0.01-0.1): (2-5).
[0008] Further, when preparing the compound DC1-S1, the volume ratio of deionized water to xylene solvent is 1:3-8.
[0009] Furthermore, in preparing the compound DC1-S1, the weight ratio of 5-bromofuran-2-carboxaldehyde to deionized water is 1:3-8; the weight ratio of 4-(diphenylamino)phenylboronic acid to deionized water is 1:1-4; the weight ratio of tetra(triphenylphosphine)palladium to deionized water is 1:10-20; and the weight ratio of potassium carbonate to deionized water is 1:1-3.
[0010] Furthermore, in step 2, when preparing compound DC1-S2, the molar ratio of compound 2-(1-(4-pyridyl)ethylidene)malonitrile to DC1-S1 is 1:0.5-2; the weight ratio of compound 2-(1-(4-pyridyl)ethylidene)malonitrile to acetonitrile is 1:30-50; and the weight ratio of compound DC1-S1 to acetonitrile is 1:10-25.
[0011] Furthermore, in step 3, the molar ratio of compound DC1-S2 to iodomethane is 1:1-3; the weight ratio of compound DC1-S2 to acetonitrile is 1:30-50; and the weight ratio of compound iodomethane to acetonitrile is 1:50-80.
[0012] Furthermore, in step 1, the eluent used for separation and purification is a mixture of petroleum ether and ethyl acetate with a volume ratio of 4-6:1; in step 2, the eluent used for separation and purification is a mixture of petroleum ether and ethyl acetate with a volume ratio of 1-3:1; and in step 3, the eluent used for separation and purification is a mixture of dichloromethane and methanol with a volume ratio of 5-15:1.
[0013] This invention also provides the application of the above-mentioned organic small molecule photosensitizer for photodynamic sterilization in the preparation of antibacterial agents. Further, the antibacterial agent inhibits at least one of Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. The organic small molecule photosensitizer in the antibacterial agent can efficiently generate reactive oxygen species under light in an aqueous solution, inhibiting bacterial growth. After co-incubation of the organic small molecule photosensitizer with Staphylococcus aureus, Escherichia coli, or Pseudomonas aeruginosa, the reactive oxygen species generated by the organic small molecule photosensitizer under light can significantly reduce the survival rate of bacteria, thereby achieving the purpose of highly efficient photodynamic sterilization.
[0014] Compared with the shortcomings and deficiencies of existing technologies, the present invention has the following beneficial effects: This invention utilizes pyridine cations and malononitrile structures as electron-withdrawing groups and furan-triphenylamine structures as electron-donating groups to construct photosensitizer molecules with an intramolecular electron "acceptor-donor" structure. The synthetic route for this photosensitizer is simple and the reaction conditions are mild. The prepared organic small-molecule photosensitizer exhibits a UV absorption peak at 580 nm and an emission peak at 710 nm in water, with a large Stokes shift. Under light irradiation in aqueous solution, it can efficiently sensitize ambient oxygen into reactive oxygen species. The prepared organic small-molecule photosensitizer utilizes the electropositive nature of the pyridine cation to rapidly bind to Staphylococcus aureus through electrostatic interactions, generating high dark toxicity and phototoxicity to kill the bacteria. Utilizing the lipophilic nature of the triphenylamine structure, it binds to Escherichia coli and Pseudomonas aeruginosa through hydrophobic interactions, killing both bacteria through its own dark toxicity and the reactive oxygen species generated under light irradiation, thereby achieving photodynamic sterilization. Attached Figure Description
[0015] Figure 1 This is the absorption and emission spectrum of photosensitizer DC1 in different solvents provided in Example 2 of the present invention; Figure 2 The absorption spectrum, hydrated particle size, and material morphology captured by transmission electron microscopy of the photosensitizer DC1 provided in Example 2 of this invention after forming nano-photosensitizer in aqueous solution; Figure 3 This is the fluorescence enhancement spectrum of the photosensitizer DC1 in an aqueous solution after generating reactive oxygen species under light irradiation, as provided in Example 2 of the present invention. Figure 4 The results of the dark toxicity and phototoxicity tests of DC1 against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa provided in Example 2 of this invention are as follows. Detailed Implementation
[0016] To make the objectives, technical solutions, and advantages of this invention clearer, the invention will be further described in detail below with reference to specific embodiments. It should be understood that the specific embodiments described herein are merely illustrative and not intended to limit the invention. Example 1
[0017] The preparation method of DC1, an organic small molecule photosensitizer used for photodynamic sterilization, is as follows: Step 1: 1 g (5.71 mmol) of 5-bromofuran-2-carboxaldehyde, 1.98 g (6.86 mmol) of 4-(diphenylamino)phenylboronic acid, 330 mg (0.28 mmol) of tetrakis(triphenylphosphine)palladium, and 2.76 g (20.0 mmol) of potassium carbonate were added to 25 mL of xylene solvent. Then, 5 mL of deionized water was added to the reaction system. The mixture was heated to 80-100 °C under argon protection and stirred for 8-16 hours. Specifically, the mixture was heated to 90 °C under argon protection and stirred for 12 hours. After the reaction was completed, the mixture was cooled to room temperature to obtain the first reaction solution.
[0018] 50 mL of saturated saline solution was added to the first reaction solution, and the aqueous phase was extracted three times with 50 mL of ethyl acetate. All organic phases were combined, dried with anhydrous sodium sulfate, and concentrated by vacuum distillation to obtain the crude product. The crude product was separated and purified by column chromatography with silica gel. The eluent used was a mixture of petroleum ether and ethyl acetate with a volume ratio of 4-6:1. Specifically, a mixture of petroleum ether and ethyl acetate with a volume ratio of 5:1 was selected to obtain 1.73 g of yellow solid compound DC1-S1, with a yield of 89%.
[0019] The preparation route of compound DC1-S1 is as follows: ; 1 H NMR (600 MHz, CDCl3): δ (ppm) 9.85 (s, 1H), 7.70 (d, J = 4.0 Hz,1H), 7.52 (d, J = 8.7 Hz, 2H), 7.32 – 7.28 (m, 5H), 7.14 (d, J = 7.3 Hz, 4H), 7.09 (t, J = 7.4 Hz, 2H), 7.06 (d, J = 8.7 Hz, 2H). Step 2: 963 mg (2.84 mmol) of compound DC1-S1, 400 mg (2.36 mmol) of 2-(1-(4-pyridyl)ethylidene)malonitrile, 0.5 mL of acetic acid and 0.5 mL of 4-methylpiperidine were dissolved in 20 mL of acetonitrile. The mixture was heated to 65-85 °C and stirred for 7-13 hours under argon protection. Specifically, the mixture was heated to 75 °C and stirred for 10 hours under argon protection. After the reaction was completed, the mixture was cooled to room temperature to obtain the second reaction solution.
[0020] Add 50 mL of saturated saline solution to the second reaction solution, and extract the aqueous phase three times with 50 mL of ethyl acetate. Combine all organic phases, dry with anhydrous sodium sulfate, and concentrate by vacuum distillation to obtain the crude product. Separate and purify the crude product by column chromatography with silica gel. The eluent used is a mixture of petroleum ether and ethyl acetate with a volume ratio of 1-3:1. Specifically, a mixture of petroleum ether and ethyl acetate with a volume ratio of 2:1 was selected to obtain 667 mg of blue solid compound DC1-S2, with a yield of 48%.
[0021] The preparation route of compound DC1-S2 is as follows: ; 1 H NMR (600 MHz, CDCl3): δ (ppm) 8.84 (d, J = 6.0 Hz, 2H), 7.61 (d, J= 8.8 Hz, 2H), 7.43 (d, J = 15.0 Hz, 1H), 7.33 – 7.29 (m, 4H), 7.28 (d, J =6.0 Hz, 2H), 7.15 (d, J = 7.4 Hz, 4H), 7.11 (t, J = 7.4 Hz, 2H), 7.07 (d, J =8.8 Hz, 2H), 6.81 (d, J = 3.8 Hz, 1H), 6.69 (d, J = 3.7 Hz, 1H), 6.47 (d, J =15.1 Hz, 1H). 13 C NMR (150 MHz, CDCl3): δ (ppm) 167.0, 160.0, 150.8, 150.1,149.6, 146.9, 141.6, 133.1, 129.7, 126.3, 125.6, 124.3, 123.3, 123.1, 121.9,121.8, 119.5, 113.6, 113.0, 108.4, 79.7. HR-ESI-MS m / z : calcd. for C 33 H 23 N4O + [M+H] + 491.1866 found 491.1868. Step 3: 100 mg (0.204 mmol) of compound DC1-S2 was dissolved in 5 mL of acetonitrile solvent. Then, 58 mg (0.41 mmol) of iodomethane was added to the above solution. The resulting solution was heated to 60-80 °C and stirred for 4-8 hours. Specifically, it was heated to 70 °C and stirred for 6 hours. After the reaction was completed, the solution was cooled to room temperature to obtain the third reaction solution.
[0022] Add 50 mL of deionized water to the third reaction solution, and extract the aqueous phase three times with 50 mL of dichloromethane. Combine all organic phases, dry with anhydrous sodium sulfate, and concentrate by vacuum distillation to obtain the crude product. Separate and purify the crude product by column chromatography with silica gel. The eluent used is a mixture of dichloromethane and methanol with a volume ratio of 5-15:1, specifically a mixture of dichloromethane and methanol with a volume ratio of 10:1. 101 mg of purple solid compound DC1 was obtained, with a yield of 80%.
[0023] The preparation route of DC1 is as follows: ; 1 H NMR (600 MHz, DMSO- d 6 ) δ (ppm) 9.26 (d, J = 6.5 Hz, 2H), 8.34 (d,J = 6.8 Hz, 2H), 7.74 (d, J = 8.6 Hz, 2H), 7.37 (t, J = 7.8 Hz, 4H), 7.26 (d,J = 15.2 Hz, 2H), 7.17-7.11 (m, 3H), 7.11 (d, J = 7.7 Hz, 4H), 6.99 (d, J =8.8 Hz, 2H), 6.85 (d, J = 15.2 Hz, 1H), 4.46 (s, 3H). 13 C NMR (150 MHz, DMSO- d 6 ) δ (ppm) 163.9, 159.3, 158.4, 150.1, 149.0, 148.8, 146.6, 146.2, 134.1,129.8, 127.8, 126.3, 125.2, 124.4, 121.2, 118.1, 113.6, 112.8, 109.9, 78.5,48.3. HR-ESI-MS m / z : calcd. for C 33 H 23 N4O +[M] + 505.2023 found 505.2031. Example 2
[0024] Photodynamic antibacterial application of photosensitizer DC1: Prepare a 20 mM dimethyl sulfoxide (DMSO) solution of photosensitizer DC1 and store it in the dark at low temperature for later use.
[0025] 1. Determination of absorption and emission spectra of photosensitizer DC1 in different solvents The DC1 solution was further diluted with dimethyl sulfoxide (DMSO) to prepare 2 mL of a 1 mM test stock solution. Four groups of 20 μL test stock solutions were then added to 1980 μL of ethyl acetate (EtOAc), tetrahydrofuran (THF), methanol (MeOH), and dimethyl sulfoxide (DMSO), respectively. After thorough mixing, the UV absorption and fluorescence spectra of the solutions were measured. The experimental results are as follows: Figure 1 As shown, DC1 exhibits a maximum UV absorption peak at 580 nm and an emission peak at 710 nm in the four solvents, with a Stokes shift of 130 nm. This demonstrates that DC1 possesses a wide range of absorption wavelengths and near-infrared fluorescence emission bands.
[0026] 2. Absorption spectroscopy and morphological characterization of photosensitizer DC1 in neutral PBS solution The DC1 solution was further diluted with dimethyl sulfoxide (DMSO) to prepare 2 mL of a 1 mM test stock solution. 20 μL of the test stock solution was added to 1980 μL of neutral PBS solution, and after thorough mixing, the UV absorption spectrum, hydrated particle size, and high-resolution transmission electron microscopy (HRTEM) were measured. The experimental results are as follows: Figure 2 As shown, the maximum UV absorption peak of DC1 in PBS is at 580 nm, and the particle size distribution of DC1 in PBS is around 100 nm.
[0027] 3. Determination of reactive oxygen species generation in aqueous solution using photosensitizer DC1 Dilute the DC1 solution with DMF solution to prepare 2 mL of a 1 mM test stock solution. Add 20 μL of the test stock solution to 1980 μL of neutral PBS solution (1 mM, pH 7.4) to prepare a 10 μM photosensitizer test solution. Then add DHR123 probe stock solution to the solution to obtain a probe concentration of 20 μM. The solution was tested under 590 nm LED illumination (P = 30 mW / cm²). 2The fluorescence emission spectrum of DHR123 was excited at 470 nm and collected from 500 to 620 nm. The fluorescence spectrum changes of DHR123 were collected within an illumination time of 0–75 s (15 s intervals). To test the generation of hydroxyl radicals in DC1, DHR123 was replaced with HPF at a probe concentration of 10 μM, and the fluorescence spectrum changes of HPF were collected within an illumination time of 0–65 s (13 s intervals). The fluorescence spectrum changes are shown below. Figure 3 As shown, under 590 nm illumination, DC1 can generate reactive oxygen species (superoxide anion radicals and hydroxyl radicals), which oxidize DHR123 and HPF and are accompanied by a significant increase in fluorescence signal.
[0028] In addition, to test the singlet oxygen generation of DC1, the photosensitizer test solution was prepared using the above method, and ABDA probe stock solution was added to a concentration of 50 μM. The solution was then tested under 590 nm LED illumination (P = 30 mW / cm²). 2 The ultraviolet absorption spectra at 330-450 nm were collected, and the changes in the ultraviolet absorption spectra of ABDA were acquired within an illumination time of 0-5 min (1 min intervals). Figure 3 As shown, under 590 nm illumination, DC1 can generate reactive oxygen species (singlet oxygen), oxidizing ABDA and accompanied by a significant decrease in absorbance. The combined results of the three experiments indicate that the nano-photosensitizer DC1 can oxidize O2 and generate various reactive oxygen species (superoxide anion radicals, hydroxyl radicals, and singlet oxygen) under illumination in aqueous solution.
[0029] 4. Evaluation of the dark toxicity of photosensitizer DC1 against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. Prepare 2 mL of a 1 mM test solution using DC1 solution in neutral PBS buffer. Add pre-cultured Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa (OD100) to the solution. 600 =0.1) Dilute 10000 times, and then inoculate the bacterial culture into a 48-well plate (100 CFU / mL). -1 Continue culturing for 1 hour. Then, add different concentrations (0-20 μM) of DC1 to the bacterial suspension (DMSO content less than 5%) and incubate at 37 ℃ for 80 minutes. Spread 100 μL of the bacterial suspension onto solid LB medium. Incubate the plates at 37 ℃ for 10 hours, observe and record the number of single bacterial colonies on the plates, and calculate the survival rate of the nano-photosensitizer DC1 against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. The experimental results are as follows: Figure 4 As shown in blue, DC1 exhibits strong dark toxicity to all three types of bacteria, inhibiting bacterial reproduction and growth.
[0030] 5. Phototoxicity evaluation of photosensitizer DC1 against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. Prepare 2 mL of a 1 mM test solution using DC1 solution in neutral PBS buffer. Add pre-cultured Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa (OD100) to the solution. 600 =0.1) Dilute 10000 times, and then inoculate the bacterial culture into a 48-well plate (100 CFU / mL). -1 Continue culturing for 1 hour. Then, add different concentrations (0-20 μM) of DC1 to the bacterial culture (DMSO content less than 5%) and incubate at 37 °C for 80 minutes. Use a white LED light (590 nm; 30 mW cm⁻¹) to incubate. -2 After irradiation for 30 min, 100 μL of bacterial suspension was spread onto solid LB medium. The plates were incubated at 37℃ for 10 hours. The number of single bacterial colonies on the plates was observed and recorded, and the survival rate of the nano-photosensitizer DC1 against Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa was calculated. The experimental results are as follows: Figure 4 As shown in green, under light conditions, DC1 exhibits more significant toxicity to all three types of bacteria, with a much lower bacterial survival rate than the non-light-exposed group. Bacterial reproduction and growth are significantly inhibited, indicating that light promotes the bactericidal effect of DC1.
[0031] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, and improvements made within the spirit and principles of the present invention should be included within the protection scope of the present invention.
Claims
1. An organic small molecule photosensitizer for photodynamic sterilization, characterized in that, The general structural formula of the organic small molecule photosensitizer is shown in formula (Ⅰ): Equation (Ⅰ).
2. A method for preparing an organic small molecule photosensitizer for photodynamic sterilization as described in claim 1, characterized in that, Includes the following steps: Step 1: Add 5-bromofuran-2-carboxaldehyde, 4-(diphenylamino)phenylboronic acid, tetra(triphenylphosphine)palladium, and potassium carbonate to xylene solvent, then add deionized water, heat to 80-100℃ under argon protection and stir for 8-16 hours. After the reaction is cooled to room temperature, the first reaction solution is obtained. The first reaction solution was diluted with saturated saline solution, and the aqueous phase was extracted with ethyl acetate. All organic phases were then combined, dried, and concentrated by vacuum distillation to obtain the first crude product. The first crude product was separated and purified by column chromatography with silica gel to obtain a yellow solid compound DC1-S1. The structure of the compound DC1-S1 is as follows: ; Step 2: Add compound DC1-S1, 2-(1-(4-pyridyl)ethylidene)malonitrile, acetic acid and 4-methylpiperidine to acetonitrile solvent. Heat the resulting solution to 65-85℃ under argon protection and stir for 7-13 hours. After cooling the reaction to room temperature, the second reaction solution is obtained. The second reaction solution was diluted with saturated saline solution, and the aqueous phase was extracted with ethyl acetate. All organic phases were combined, dried, and concentrated by vacuum distillation to obtain the second crude product. The second crude product was separated and purified by column chromatography with silica gel to obtain the blue solid compound DC1-S2. The structure of the compound DC1-S2 is as follows: ; Step 3: Dissolve compound DC1-S2 in acetonitrile and add iodomethane. Heat the resulting solution to 60-80℃ and stir for 4-8 hours. After cooling the reaction to room temperature, the third reaction solution is obtained. After diluting the third reaction solution with deionized water, the aqueous phase was extracted with dichloromethane, and all organic phases were combined. The mixture was then dried and concentrated by vacuum distillation to obtain the third crude product. The third crude product was separated and purified by column chromatography with silica gel to obtain the purple solid photosensitizer shown in formula (I).
3. The method for preparing the organic small molecule photosensitizer for photodynamic sterilization as described in claim 2, characterized in that, In step 1, when preparing the compound DC1-S1, the molar ratio of 5-bromofuran-2-carboxaldehyde, 4-(diphenylamino)phenylboronic acid, tetra(triphenylphosphine)palladium and potassium carbonate is 1:1.2:(0.01-0.1):(2-5).
4. The method for preparing the organic small molecule photosensitizer for photodynamic sterilization as described in claim 3, characterized in that, The volume ratio of deionized water to xylene solvent is 1:3-8.
5. The method for preparing the organic small molecule photosensitizer for photodynamic sterilization as described in claim 4, characterized in that, The weight ratio of 5-bromofuran-2-carboxaldehyde to deionized water is 1:3-8; the weight ratio of 4-(diphenylamino)phenylboronic acid to deionized water is 1:1-4; the weight ratio of tetra(triphenylphosphine)palladium to deionized water is 1:10-20; and the weight ratio of potassium carbonate to deionized water is 1:1-3.
6. The method for preparing the organic small molecule photosensitizer for photodynamic sterilization as described in claim 2, characterized in that, In step 2, when preparing compound DC1-S2, the molar ratio of compound 2-(1-(4-pyridyl)ethylidene)malonitrile to DC1-S1 is 1:0.5-2; the weight ratio of compound 2-(1-(4-pyridyl)ethylidene)malonitrile to acetonitrile is 1:30-50; and the weight ratio of compound DC1-S1 to acetonitrile is 1:10-25.
7. The method for preparing the organic small molecule photosensitizer for photodynamic sterilization as described in claim 2, characterized in that, In step 3, the molar ratio of compound DC1-S2 to iodomethane is 1:1-3; the weight ratio of compound DC1-S2 to acetonitrile is 1:30-50; and the weight ratio of compound iodomethane to acetonitrile is 1:50-80.
8. The method for preparing the organic small molecule photosensitizer for photodynamic sterilization as described in claim 2, characterized in that, In step 1, the eluent used for separation and purification is a mixture of petroleum ether and ethyl acetate with a volume ratio of 4-6:1; in step 2, the eluent used for separation and purification is a mixture of petroleum ether and ethyl acetate with a volume ratio of 1-3:1; in step 3, the eluent used for separation and purification is a mixture of dichloromethane and methanol with a volume ratio of 5-15:
1.
9. The application of the organic small molecule photosensitizer for photodynamic sterilization as described in claim 1 in the preparation of antibacterial agents.
10. The application as described in claim 9, characterized in that, The antibacterial agent inhibits at least one of the following bacteria: Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa.
